Construction and Characterization of Soluble, Cleaved, and Stabilized Trimeric Env Proteins Based on HIV Type 1 Env Subtype A
- 1 June 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 22 (6) , 569-579
- https://doi.org/10.1089/aid.2006.22.569
Abstract
The generation of an antibody response capable of neutralizing a broad range of clinical isolates remains an important goal of human immunodeficiency virus type 1 (HIV-1) vaccine development. Envelope glycoprotein (Env)-based vaccine candidates will also need to take into account the extensive genetic diversity of circulating HIV-1 strains. We describe here the generation of soluble, stabilized, proteolytically cleaved, trimeric forms of Env (SOSIP gp140 proteins) based on contemporary Env subtype A viruses from East Africa. We discuss issues associated with the construction, purification, and characterization of such complex proteins; not all env sequences allow the expression of trimeric proteins. However, stabilized trimers from one such protein, KNH1144 SOSIP gp140, were successfully made. These proteins are now being prepared for preclinical immunogenicity studies.Keywords
This publication has 94 references indexed in Scilit:
- Biologic and Genetic Characterization of a Panel of 60 Human Immunodeficiency Virus Type 1 Isolates, Representing Clades A, B, C, D, CRF01_AE, and CRF02_AG, for the Development and Assessment of Candidate VaccinesJournal of Virology, 2005
- Lessons from Failure—Preparing for Future HIV‐1 Vaccine Efficacy TrialsThe Journal of Infectious Diseases, 2005
- Genetic Diversity and High Proportion of Intersubtype Recombinants among HIV Type 1-Infected Pregnant Women in Kisumu, Western KenyaAIDS Research and Human Retroviruses, 2004
- Promoting Trimerization of Soluble Human Immunodeficiency Virus Type 1 (HIV-1) Env through the Use of HIV-1/Simian Immunodeficiency Virus ChimerasJournal of Virology, 2004
- A Novel Human Antibody against Human Immunodeficiency Virus Type 1 gp120 Is V1, V2, and V3 Loop Dependent and Helps Delimit the Epitope of the Broadly Neutralizing Antibody Immunoglobulin G1 b12Journal of Virology, 2003
- Effects of HIV Type 1 Envelope Glycoprotein Proteolytic Processing on AntigenicityAIDS Research and Human Retroviruses, 2003
- Nonneutralizing Antibodies to the CD4-Binding Site on the gp120 Subunit of Human Immunodeficiency Virus Type 1 Do Not Interfere with the Activity of a Neutralizing Antibody against the Same SiteJournal of Virology, 2003
- Clinical Trials of HIV VaccinesAnnual Review of Medicine, 2002
- CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5Nature, 1996
- The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processingVirology, 1990